Identification of CD133+ Cells in Pituitary Adenomas

Stem-like cells in tumors are capable of self-renewal and pluri-differentiation; they are thought to play important roles in tumor initiation and maintenance. Stem-like cells in malignant glioma express CD133. We examined samples from human pituitary adenoma, a generally benign neoplasm, for CD133 expression using routine immunohistochemical and biochemical methods. Our study of 70 pituitary adenomas (clinically nonfunctioning adenomas and growth hormone-, prolactin-, adrenocorticotropic hormone-, and thyroid-stimulating hormone-producing adenomas) showed that 18 (25.7%) expressed CD133. This rate was higher in clinically nonfunctioning (33.3%) than functioning adenomas (12.0%) (p = 0.085). Real-time PCR assay revealed the expression of CD133 mRNA in samples immunohistochemically positive for CD133. Neither the patient age and gender, nor the tumor size or postoperative recurrence rate correlated with CD133 positivity. CD133+ cells ubiquitously coexpressed CD34, nestin, and VEGFR2 (KDL1). S-100 and GFAP were not coexpressed with CD133. Chromogranin A, Pit-1, SF-1, and NeuroD1 were immune-negative, indicating that CD133+ cells did not have the potential to differentiate into functional endocrine cells. Our data suggest that the expression of CD133 in pituitary adenomas is related to immature endothelial progenitor cells that may play a role in the neovascularization of pituitary adenomas. Further studies are needed to elucidate the significance of CD133+ cells with respect to neovascularization and their sustainable growth in pituitary adenomas.

[1]  J. Montaner,et al.  Mobilization, endothelial differentiation and functional capacity of endothelial progenitor cells after ischemic stroke. , 2010, Microvascular research.

[2]  J. Koivukangas,et al.  Incidence of pituitary adenomas in Northern Finland in 1992-2007. , 2010, The Journal of clinical endocrinology and metabolism.

[3]  K. Black,et al.  Isolation of tumour stem-like cells from benign tumours , 2009, British Journal of Cancer.

[4]  P. Wesseling,et al.  Collision sellar lesions: experience with eight cases and review of the literature , 2009, Pituitary.

[5]  M. Hristov,et al.  Endothelial progenitor cells in vascular repair and remodeling. , 2008, Pharmacological research.

[6]  Mahlon D. Johnson,et al.  Neuronal Differentiation and Expression of Neural Epitopes in Pituitary Adenomas , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[7]  S. Kang,et al.  Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. , 2007, Stem cells and development.

[8]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[9]  E. Holland,et al.  Radiation Resistance and Stem-Like Cells in Brain Tumors (DOI: 10.1016/j.ccr.2006.11.008) , 2007 .

[10]  G. Camussi,et al.  CD133+ renal progenitor cells contribute to tumor angiogenesis. , 2006, The American journal of pathology.

[11]  E. Holland,et al.  Radiation resistance and stem-like cells in brain tumors. , 2006, Cancer cell.

[12]  G. Nickenig,et al.  CD34−/CD133+/VEGFR-2+ Endothelial Progenitor Cell Subpopulation With Potent Vasoregenerative Capacities , 2006, Circulation research.

[13]  M. Niveiro,et al.  Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas. , 2005, Human pathology.

[14]  H. Vankelecom,et al.  The adult pituitary contains a cell population displaying stem/progenitor cell and early embryonic characteristics. , 2005, Endocrinology.

[15]  Meng Yang,et al.  Nestin-linked green fluorescent protein transgenic nude mouse for imaging human tumor angiogenesis. , 2005, Cancer research.

[16]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[17]  T. Schmid,et al.  CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer , 2004, Journal of Clinical Pathology.

[18]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[19]  D. Neal,et al.  CD133, a novel marker for human prostatic epithelial stem cells , 2004, Journal of Cell Science.

[20]  D. Ribatti.  The involvement of endothelial progenitor cells in tumor angiogenesis , 2004, Journal of cellular and molecular medicine.

[21]  Jacqueline Murray,et al.  Fibronectin promotes VEGF-induced CD34 cell differentiation into endothelial cells. , 2004, Journal of vascular surgery.

[22]  T. Schmid,et al.  CD 133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer , 2004 .

[23]  W. Huttner,et al.  Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer , 2004, Cell and Tissue Research.

[24]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[25]  T. Hayakawa,et al.  CD31 (PECAM‐1)‐bright cells derived from AC133‐positive cells in human peripheral blood as endothelial‐precursor cells , 2003, Journal of cellular physiology.

[26]  J. Živný,et al.  Expression of genes regulating angiogenesis in human circulating hematopoietic cord blood CD34+/CD133+ cells , 2003, European journal of haematology.

[27]  K. Kovacs,et al.  Folliculo-stellate Cells of the Human Pituitary: A Type of Adult Stem Cell? , 2002, Ultrastructural pathology.

[28]  Anthony Atala,et al.  Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo , 2001, Nature Medicine.

[29]  K. Pantel,et al.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells , 2000 .

[30]  G. Reifenberger,et al.  Mixed gangliocytoma/pituitary adenoma. , 2000, Archives of neurology.

[31]  S. Rafii,et al.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.

[32]  K. Pantel,et al.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells. , 1999, Blood.

[33]  R. Hebbel,et al.  Origins of circulating endothelial cells and endothelial outgrowth from blood. , 2000, The Journal of clinical investigation.

[34]  S. Nemecek,et al.  Cerebral angiogenesis shows nestin expression in endothelial cells. , 1999, General physiology and biophysics.

[35]  H. Randeva,et al.  Classical pituitary apoplexy: clinical features, management and outcome , 1999, Clinical endocrinology.

[36]  S. Rafii,et al.  Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.

[37]  J. Kearney,et al.  AC133, a novel marker for human hematopoietic stem and progenitor cells. , 1997, Blood.

[38]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[39]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[40]  B. Scheithauer,et al.  The immunophenotype of pituitary adenomas , 1996, Endocrine pathology.

[41]  K. Alitalo,et al.  Endothelial receptor tyrosine kinases involved in angiogenesis , 1995, The Journal of cell biology.